ABSTRACT
Ubiquitylation is a versatile post-translational modification mechanism used by eukaryotic cells (10) . It is catalyzed through a pathway involving three enzymes, E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin ligase). E3 is the most diverse, and it determines substrate specificity and the rate of ubiquitin conjugation. Substrates can be modified with monoubiquitin or with a polyubiquitin chain that is linked through lysines present within ubiquitin itself. The most common polyubiquitylation is linked through lysine 48 of ubiquitin which serves as a signal for the rapid degradation of substrate by the proteasome-dependent pathway (2) . However, recent studies have revealed roles other than proteolysis for polyubiquitylation (17) . While lysine 48-and lysine 29-linked polyubiquitin chains mediate proteasome-dependent degradation, lysine 63-linked polyubiquitin chains are a signal for endocytosis, IκB kinase activation, ribosome modification, and DNA repair (4, 7, 11, 20, 21) . Although it has been reported that lysine 6-linked polyubiquitin chains are deubiquitylated by the 26 S proteasome and are not thought to be a proteasomal degradation signal (15) , detailed biological function of lysine 6-linked polyubiquitin is not well understood.
A RING-H2 type E3 ubiquitin ligase Pirh2 (p53-inducible protein with RING-H2 domain), also known as androgen receptor N-terminal-interacting protein (ARNIP) (1) , was identified as a p53-inducible and -interacting protein which promotes ubiquitylation and degradation of p53 (12) . Other studies have shown that Pirh2 interacts with various molecules including histone acetylase TIP60 (Tatinteractive protein of 60 kDa) (18) , measles virus (Invitrogen, Carlsbad, CA, USA), α-tubulin (DM1A; Sigma), and β-actin (AC-15; Sigma) were used for immunoprecipitation and/or immunoblotting. Polyclonal antibody against SRβ was raised in rabbit by standard procedures using the carboxy-terminus fragment of recombinant GST-hSRβ (residues 87-271) as antigens and purified by a Melon™ Gel IgG Purification kit (PIERCE, Rockford, IL, USA).
Mammalian expression vectors and transfection.
Human wild-type and RING finger mutant (C148A) Pirh2 expression vectors were constructed as described previously (9) . Human SRβ cDNA was amplified by RT-PCR from HCT116 cell RNA and cloned into the pcDNA4-HisMax expression vector (Invitrogen). The resultant pcDNA4-HisMax-SRβ encodes 6×His and the Xpress epitope tag fused with the amino terminus of human SRβ. pCMV-2× FLAG-SRβ was constructed by ligating FLAG-SRβ cDNA into the pCMV-Tag2 expression vector (Stratagene, La Jolla, CA, USA). HEK293 and COS-1 cells were transfected by the calcium phosphate method. U2OS cells were transfected using Fu-GENE6 (Roche) according to the manufacturer's protocol. Small interfering RNA (siRNA) duplexes for Pirh2 were described previously (9) . Non-silencing control siRNA was obtained from Qiagen (Valencia, CA, USA). The cells were transfected with siRNA by using Oligofectamine (Invitrogen) according to manufacturer's protocol.
Immunoprecipitation and immunoblotting. Cells were lysed in immunoprecipitation lysis buffer (0.5% Triton X-100, 150 mM NaCl, 20 mM Tris-HCl, pH 7.6, and protease inhibitor mix). Immunoprecipitation and immunoblotting were performed as described previously (9) .
Immunofluorescence. COS-1 cells were cotransfected with Xpress-Pirh2 and 2×FLAG-SRβ expression plasmids. After 48 h, the cells were fixed with 4% paraformaldehyde in PBS (−), permeabilized with 0.2% Triton X-100 in PBS (-), blocked with 10% normal goat serum, and treated with anti-FLAG antibody conjugated with AlexaFluor546 and antiXpress antibody conjugated with AlexaFluor488. The ER was stained using the ER labeling kit according to the manufacturer's protocol (Molecular Probe, Eugene, OR, USA). Fluorescence images were taken under fluorescence microscope system (Biozero, KEYENCE, Tokyo, Japan).
phosphoprotein (3) , N-terminal kinase-like proteinbinding protein 1 (NTKL-BP1) (22) , and calmodulin (5) . Recently, it has been reported that histone deacetylase 1 (HDAC1) and the ε-subunit of coatomer complex (ε-COP) were ubiquitylated and subsequently degraded by Pirh2 (13, 14) . Moreover, we had found that Pirh2 promotes ubiquitin-dependent degradation of the CDK inhibitor p27
Kip1 at the G1/S phase of the cell cycle (9) . These studies suggest that Pirh2 is involved in various cellular events by ubiquitylating and/or interacting with these molecules.
Secretory proteins are synthesized with an N-terminal hydrophobic signal sequence. As the signal sequence emerges from the ribosome, it is recognized by the signal recognition particle (SRP) and subsequently targeting of the ribosome-nascent chain complex to the endoplasmic reticulum (ER) membrane occurs. At the membrane, SRP contacts the SRP receptor (SR), a heterodimer composed of SRα and SRβ. Contact between SRP and SRα leads to the transfer of the nascent chain from SRP into the lumen of the ER through the translocation channel formed by the Sec61p complex (6, 8) .
In this study, we identified SRβ as a novel Pirh2-interacting protein by yeast two-hybrid screening. We found that Pirh2 promoted ubiquitylation of SRβ without affecting the stability of SRβ. Our findings suggest that Pirh2 may control the synthesis of secretory protein by the functional regulation of SRβ via ubiquitylation.
MATERIALS AND METHODS
Yeast two-hybrid screening. The yeast two-hybrid screening was performed with the Matchmaker TwoHybrid System 2 (Clontech, Mountain View, CA, USA). The full-length rat Pirh2 was cloned into the yeast two-hybrid vector pAS2-1 and the plasmid was transformed into the yeast followed by screening a pACT2 rat brain cDNA library (Clontech) according to the manufacturer's instructions.
Cell culture, reagents, and antibodies. All cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal bovine serum and antibiotics. MG132 (Peptide institute, Osaka, Japan) and cycloheximide (Wako, Osaka, Japan) were purchased. Polyclonal antibody against Pirh2 (Calbiochem, San Diego, CA, USA) was pur- 
Pirh2 ubiquitylates SRβ in vivo as well as in vitro
To examine whether Pirh2 can promote ubiquitylation of SRβ in vivo, 2×FLAG-SRβ and HA-ubiquitin expression plasmids were cotransfected into HEK293 cells together with Xpress-Pirh2 or -Pirh2 RING mutant (in which residue cysteine 148 within the RING finger domain was replaced with alanine (C148A)) expression plasmid. The cell extracts were subjected to immunoblotting with anti-FLAG antibody. When HA-tagged ubiquitin was cotransfected together with SRβ, the amount of ubiquitylated SRβ protein was increased ( Fig. 2A, left panel) . Cotransfection with wild-type Pirh2 (wt) enhanced ubiquitylation of SRβ, which was not observed in the absence of Pirh2 or when cotransfected with the RING mutant (mt) Pirh2. To demonstrate that the high-molecular-mass species recognized by the anti-FLAG antibody is polyubiquitin-conjugated SRβ, SRβ was immunoprecipitated twice as described in legend for Fig. 2A . Then the immunoprecipitates were subjected to immunoblotting with anti-FLAG antibody for detection of SRβ as well as with anti-HA antibody for detection of the ubiquitin chain ( Fig. 2A, right and middle panels). In this experiment, anti-HA antibody detects only HA-ubiquitylated SRβ but not HA-ubiquitylation of the other coprecipitated proteins. Immunoblots with anti-FLAG and anti-HA antibodies gave ladders with similar mobility shifts identical to the molecular mass of a ubiquitin chain (note that (Ub) 1 SRβ or (Ub) 2 SRβ equally migrated in all panels of Fig. 2 ). These results indicated that Pirh2 promotes ubiquitylation of SRβ in a RING finger domain-dependent manner.
We then investigated whether Pirh2-induced ubiquitylation of SRβ can be reconstituted with purified components. Pirh2-mediated ubiquitylation of SRβ
In vitro ubiquitylation assay. GST-tagged FLAG-SRβ, Pirh2, and Pirh2 (C148A) proteins were expressed in Escherichia Coli BL21-CodonPlus (DE3) (Stratagene) and affinity-purified with glutathioneSepharose 4B (GE Healthcare, Buckinghamshire, UK), and then the GST tag was removed by cleavage with PreScission protease (GE Healthcare). FLAG-SRβ protein was incubated with or without Pirh2 protein at 30°C for 60 min in a 20 μL ubiquitylation mixture supplemented with 50 mM TrisHCl, pH 8.3, 5 mM MgCl 2 , 2 mM DTT, 10 mM phosphocreatinine, 0.2 units/mL phosphocreatinine kinase, 5 mM adenosine-5'-triphosphate, 2 μL of GST-ubiquitin or His-ubiquitin, 250 μM MG132, protease inhibitor mix, E1 (120 ng, Boston Biochem, Cambridge, MA, USA), and UbcH5b (500 ng, Boston Biochem). After incubation, the reactants were subjected to immunoblotting with anti-FLAG antibody.
RESULTS

Identification of SRβ as a Pirh2-interacting protein
To identify novel interacting proteins with Pirh2, we performed yeast two-hybrid screening of a rat brain cDNA library using full-length Pirh2 as bait and found that Pirh2 interacted with signal recognition particle receptor β subunit (SRβ), a membrane protein of the endoplasmic reticulum (ER) essential for protein translocation across the ER membrane. To determine whether SRβ physically interacts with Pirh2 in mammalian cells, we coexpressed the 4× FLAG-Pirh2 and Xpress-SRβ in HEK293 cells. When extracts from transfected cells were immunoprecipitated with anti-FLAG antibody and immunoblotted with anti-Xpress antibody, SRβ was only coprecipitated in the presence of transfected Pirh2 (Fig. 1A , IP: FLAG and IB: Xpress). In a reciprocal experiment using anti-Xpress antibody for immunoprecipitation, coprecipitated Pirh2 was observed in cells transfected with the Xpress SRβ plasmid but not in cells transfected with an empty vector (Fig. 1A , IP: Xpress and IB: FLAG). To further confirm this interaction, we examined whether transfected SRβ would associate with endogenous Pirh2. HEK293 cells were transfected with 2×FLAG SRβ, and the cell extracts were subjected to immunoprecipitation with anti-FLAG antibody and immunoblotted with anti-Pirh2 antibody. As shown in Fig. 1B , endogenous Pirh2 was coprecipitated with SRβ only when 2×FLAG SRβ was transfected. Taken together, these results suggest that Pirh2 and SRβ physically interact with each other in mammalian cells. In order to
Pirh2 is not involved in the regulation of SRβ protein stability
Polyubiquitin conjugation is a key signal which marks target proteins to the proteasome. We then examined whether Pirh2 can regulate the stability of SRβ in cells because Pirh2 facilitated the ubiquitylation of SRβ. To investigate the effects of expression of Pirh2 on SRβ stability, 2×FLAG-SRβ was transiently transfected into U2OS cells with or without Xpress-tagged wild-type Pirh2 or RING finger mutant (C148A) Pirh2. Unexpectedly, the steadystate level of SRβ was not affected in cells transfected with either wild-type or mutant Pirh2 compared with that in the absence of Pirh2 (Fig. 3A,  lanes 1-3) . Treatment with proteasome inhibitor, was detected only when all of the reaction components were present and depended on the existence of an intact RING finger domain of Pirh2 (Fig. 2B) . In this in vitro ubiquitylation assay, the high-molecular-mass bands detected by anti-FLAG antibody disappeared when lysine free GST-ubiquitin was employed instead of wild-type GST-ubiquitin (Fig. 2C ). This result indicated that SRβ ubiquitylation induced by Pirh2 directly consisted of a polymerization reaction of the ubiquitin chain but not monoubiquitylation of multiple lysines on SRβ. Therefore, these observations strongly suggested that Pirh2 directly polyubiquitylated SRβ as a substrate for Pirh2. MG132 or de novo protein synthesis inhibitor, cycloheximide did not alter the SRβ expression level regardless of coexpression of Pirh2 or its mutant (Fig. 3A, lanes 4-9) . Moreover, we analyzed the effect of Pirh2 expression on the half-life of SRβ protein by cycloheximide assay. Again, coexpression of wild-type or mutant Pirh2 did not alter the stability of SRβ protein (Fig. 3B) HEK293 cells were cotransfected with 2×FLAG-SR and HA-ubiquitin expression plasmids with or without wild-type Pirh2 (wt) or RING finger mutant Pirh2 (mt) expression plasmid. At 40 h after transfection, cells were treated with 10 µM MG132 for 8 h. The cells were lysed, separated by SDS-PAGE, and immunoblotted (IB) with anti-FLAG and anti-Xpress antibodies (input, left panel). Alternatively, the cell lysates were immunoprecipitated (IP) with anti-FLAG antibody. The immunocomplex was denatured in Laemmli's sample buffer containing SDS and 2-mercaptoethanol to dissociate contaminant proteins associated with FLAG-SR . FLAG-SR was reimmunoprecipitated with anti-FLAG antibody (2×IP: FLAG) and immunoblotted (IB) with anti-HA (middle panel) and anti-FLAG (right panel) antibodies. B: Pirh2 ubiquitylated SR in vitro. Purified FLAG-SR was incubated with GSTubiquitin in the presence or absence of recombinant wild-type Pirh2 (wt) or RING finger mutant Pirh2 (mt) in the in vitro ubiquitylation buffer. The reactants were separated by SDS-PAGE and detected with anti-FLAG antibody. Asterisk shows the bands derived from miss-cleaved GST-tagged FLAG-SR . C: Pirh2 induced poly-ubiquitylation but not multi-ubiquitylation of SR . Recombinant FLAG-SR was incubated with wild-type GST-ubiquitin (WT) or lysine free GST-ubiquitin (K (−)) together with recombinant Pirh2 in the in vitro ubiquitylation buffer. The reactants were analyzed as described in (B). residues 6 and/or 29 of the ubiquitin, consistent with the notion that Pirh2 did not regulate SRβ protein stability.
DISCUSSION
We reported here for the first time that Pirh2 interacts with and ubiquitylates SRβ essential for the protein translocation across the ER in the synthesis of secretory protein. Immunocytochemical studies revealed that Pirh2 colocalized with SRβ in the ER when the two expression plasmids were cotransfected into the same cells. On the other hand, Pirh2 was widely distributed throughout the cells when Pirh2 was transfected alone (Figs.1C-Q) . These data suggested that Pirh2 can bind to SRβ on the ER and may function as a ubiquitin ligase for SRβ.
Unexpectedly, different from the case of other Pirh2 substrates such as p53, HDAC1 and p27
Kip1
, neither overexpression nor depletion of Pirh2 affected the expression level and stability of the SRβ protein. Our studies further suggested that Pirh2
Pirh2 cannot mediate the polyubiquitylation of SRβ when lysine residue 6 or 29 of ubiquitin is substituted with arginine
The formation of a polyubiquitin chain by linkage of one ubiquitin moiety to lysine 48 (K48) of the adjacent ubiquitin had been thought to be a signal marking the target proteins for proteolysis by the 26 S proteasome. However, recent studies demonstrated that polyubiquitin chains can also be assembled via lysine residues of ubiquitin other than K48, and the resulting ubiquitin chains function in indistinct biological processes (4, 7, 11, 15, 17, 20, 21) . To determine which lysine residues of ubiquitin are required for polyubiquitylation of SRβ by Pirh2, we performed an in vitro ubiquitylation assay using 6× His-tagged ubiquitin mutants in which the lysine residue at position 6, 11, 29, 48, or 63 was individually replaced with arginine (Fig. 4A) . As shown in Fig. 4B , Pirh2 was unable to mediate polyubiquitylation of SRβ with a ubiquitin mutant K6R and K29R. These data suggested that SRβ polyubiquitylation mediated by Pirh2 was assembled via lysine Overexpression of Pirh2 in a prostate cancer cell line caused downregulation of the secretion of prostate-specific antigen (PSA), a secretory protein in prostate epithelial cells (14) . Therefore, Pirh2 may control not only secretion of PSA but also the secretory protein synthesis machinery itself by promoting ubiquitylation of SRβ.
Thus, it is probable that Pirh2 functions not only in cancer cell proliferation by promoting the degradation of p53, HDAC1 and p27 kip1 in a ubiquitinproteasome pathway, but functions also in the synthesis of secretory protein by the functional regulation of SRβ via interaction or ubiquitylation. for Science Research from the Ministry of Education, Science, Sports, Culture and Technology of Japreferentially utilized lysine residues 6 and 29 of the ubiquitin to mediate the polyubiquitylation of SRβ. The function of lysine 6-linked polyubiquitylation is yet to be determined. However, given that the lysine 6-linked polyubiquitin chain is not a proteasomal degradation signal, it is suggested that ubiquitylation of SRβ by Pirh2 does not serve exclusively as the degradation signal for the proteasome. As discussed above, lysine 6-linked polyubiquitylation of SRβ mediated by Pirh2 may serve as a regulatory ubiquitylation for the SRP-SR complex in the synthesis of secretory proteins without affecting the stability of SRβ per se. In any case, further studies are required to determine which lysine residues Pirh2 preferentially utilizes in ubiquitylating SRβ in vivo.
Recently, it was reported that Pirh2 ubiquitylated ε-COP, a subunit of the COP I coatomer complex, which coats the Golgi-derived vesicles involved in protein transport from the Golgi apparatus to the ER and within the Golgi apparatus (16, 19) , and consequently promoted the degradation of ε-COP (14) . 
